Stockreport

First Patient Enrolls in STEMI DTU Randomized Controlled FDA Trial; Study Aims to Further Demonstrate Impella’s Safety and Effectiveness

ABIOMED, Inc.  (ABMD) 
Last abiomed, inc. earnings: 4/30 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: investors.abiomed.com/investor-relations
PDF DANVERS, Mass.--(BUSINESS WIRE)--Abiomed (NASDAQ: ABMD) announces initiation of the ST-Elevation Myocardial Infarction Door-to-Unloading (STEMI DTU) Pivotal Randomiz [Read more]